Prof Dr Dirk Brenner joins the Editorial Board of “Cell Death Differentiation”, Springer Nature

• Experimental and Molecular Immunology

We are delighted to announce that Prof. Dr. Dirk Brenner has been appointed to the high-level Editorial Board of Cell Death Differentiation (CDD), a prestigious journal published by Springer Nature. Prof. Dr. Brenner’s term will extend over the next three years.

Published in London since its inception in 1994, Cell Death Differentiation has consistently maintained a high impact factor of 12.4, establishing itself as a leader in the fields of cell biology, molecular research, and biochemistry. The journal is dedicated to fostering scientific excellence and serves as a vital platform for both scientists and clinical researchers. Its focus is on the rapid dissemination of high-quality research papers, alongside invited reviews, meeting reports, editorials, and discussions on pivotal topics within the realm of cell death and disease.

Prof. Dr. Brenner’s role on the board will include overseeing the journal’s review process, enhancing its promotion, and attracting top-tier scientific papers, thereby contributing to the ongoing success and influence of CDD in its field.

About Springer Nature:

Springer Nature is a global publisher dedicated to providing the best possible service to the whole research community. We help researchers excel at all stages of their careers, ensure that their discoveries are disseminated rapidly, and beyond the academic community.